X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2020) 2020
Newsletter (148) 148
Newspaper Article (24) 24
Magazine Article (10) 10
Dissertation (8) 8
Book Chapter (5) 5
Book Review (3) 3
Conference Proceeding (3) 3
Government Document (2) 2
Publication (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
gemfibrozil (1278) 1278
science & technology (1162) 1162
humans (1151) 1151
life sciences & biomedicine (1090) 1090
male (803) 803
gemfibrozil - therapeutic use (591) 591
middle aged (526) 526
female (517) 517
adult (396) 396
hypolipidemic agents - therapeutic use (394) 394
gemfibrozil - pharmacology (382) 382
animals (348) 348
pharmacology & pharmacy (309) 309
triglycerides - blood (300) 300
aged (278) 278
fibric acids (252) 252
abridged index medicus (248) 248
hypolipidemic agents - pharmacology (221) 221
gemfibrozil - adverse effects (206) 206
hyperlipidemias - drug therapy (205) 205
cholesterol - blood (204) 204
cholesterol, hdl - blood (199) 199
cardiovascular system & cardiology (190) 190
rats (161) 161
drug interactions (159) 159
cholesterol, ldl - blood (155) 155
cardiac & cardiovascular systems (153) 153
drug therapy, combination (152) 152
environmental sciences (152) 152
environmental sciences & ecology (152) 152
risk factors (151) 151
cholesterol (144) 144
drugs (143) 143
lipids - blood (142) 142
gemfibrozil - administration & dosage (138) 138
hypolipidemic agents - adverse effects (137) 137
physical sciences (136) 136
analysis (132) 132
general & internal medicine (131) 131
medicine, general & internal (129) 129
double-blind method (128) 128
research (115) 115
hypertriglyceridemia - drug therapy (114) 114
lipids (109) 109
peripheral vascular disease (108) 108
chemistry (103) 103
hydroxymethylglutaryl-coa reductase inhibitors - therapeutic use (101) 101
drug therapy (100) 100
coronary disease - prevention & control (99) 99
lipoproteins - blood (99) 99
hypercholesterolemia - drug therapy (98) 98
pharmaceuticals (97) 97
biochemistry & molecular biology (96) 96
hyperlipidemias - blood (94) 94
lovastatin - therapeutic use (94) 94
hypolipidemic agents - administration & dosage (93) 93
treatment outcome (89) 89
fibrates (87) 87
triglycerides (87) 87
physiological aspects (84) 84
mice (83) 83
endocrinology & metabolism (81) 81
toxicology (81) 81
liver - drug effects (79) 79
anticholesteremic agents - therapeutic use (78) 78
gemfibrozil - pharmacokinetics (78) 78
technology (77) 77
time factors (77) 77
fenofibrate (76) 76
clinical trials as topic (75) 75
pentanoic acids - therapeutic use (75) 75
rhabdomyolysis - chemically induced (75) 75
simvastatin (74) 74
statins (74) 74
hyperlipidemia (71) 71
atherosclerosis (69) 69
ibuprofen (69) 69
coronary heart disease (68) 68
niacin - therapeutic use (68) 68
liver - metabolism (66) 66
engineering (65) 65
water pollutants, chemical - analysis (64) 64
fenofibrate - therapeutic use (63) 63
gemfibrozil - chemistry (63) 63
wastewater (63) 63
cross-over studies (62) 62
lipoproteins, hdl - blood (62) 62
fenofibrate - pharmacology (61) 61
bezafibrate - pharmacology (59) 59
carbamazepine (59) 59
hydroxymethylglutaryl-coa reductase inhibitors - adverse effects (59) 59
lipoproteins, ldl - blood (59) 59
sewage (59) 59
hypertriglyceridemia - blood (58) 58
dose-response relationship, drug (57) 57
rats, sprague-dawley (57) 57
gemfibrozil - toxicity (56) 56
hypercholesterolemia - blood (56) 56
kinetics (56) 56
low density lipoproteins (55) 55
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2130) 2130
Spanish (34) 34
German (15) 15
Japanese (15) 15
French (11) 11
Portuguese (11) 11
Chinese (9) 9
Russian (7) 7
Italian (6) 6
Hungarian (5) 5
Polish (5) 5
Swedish (4) 4
Korean (3) 3
Czech (2) 2
Turkish (2) 2
Bulgarian (1) 1
Croatian (1) 1
Danish (1) 1
Dutch (1) 1
Finnish (1) 1
Hebrew (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Neurotoxicity research, ISSN 1029-8428, 07/2012, Volume 23, Issue 3, pp. 225 - 237
Two important pathophysiological mechanisms involved during cerebral ischemia are oxidative stress and inflammation. In pathological conditions such as brain... 
Neurochemistry | Global cerebral ischemia–reperfusion | Neurosciences | Neurobiology | Sex | Inflammation | Cell Biology | Antioxidant defense system | Neurology | Biomedicine | Gemfibrozil | Nrf-2 pathway | Pharmacology/Toxicology | Global cerebral ischemia-reperfusion | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | NF-E2-Related Factor 2 - physiology | Neuroprotective Agents - therapeutic use | Rats, Wistar | Brain Ischemia - metabolism | Gemfibrozil - therapeutic use | Male | NF-kappa B - metabolism | Hippocampus - drug effects | Nerve Degeneration - chemically induced | Gemfibrozil - toxicity | Neuroprotective Agents - pharmacology | Glutathione - analysis | Lipid Peroxidation - drug effects | Nerve Tissue Proteins - biosynthesis | Anti-Inflammatory Agents - therapeutic use | Anti-Inflammatory Agents - administration & dosage | Female | Neuroprotective Agents - administration & dosage | Gemfibrozil - administration & dosage | Anti-Inflammatory Agents - pharmacology | Anti-Inflammatory Agents - toxicity | Rats | Neuroprotective Agents - toxicity | Hippocampus - pathology | Antioxidants - pharmacology | Brain Ischemia - etiology | Gemfibrozil - pharmacology | Random Allocation | Sex Characteristics | Nerve Tissue Proteins - genetics | Antioxidants - toxicity | Gene Expression Regulation - drug effects | Hippocampus - metabolism | Antioxidants - therapeutic use | Animals | Reperfusion Injury - prevention & control | Signal Transduction - drug effects | Brain Ischemia - drug therapy | Oxidative Stress - drug effects | Premedication | Antioxidants | COX-2 inhibitors | Defense industry | Cerebral ischemia | Models | Superoxide | Fibric acids | Index Medicus
Journal Article
Drug metabolism and disposition, ISSN 1521-009X, 08/2007, Volume 35, Issue 8, pp. 1308 - 1314
Hepatic uptake carriers of the organic anion-transporting peptide (OATP) family of solute carriers are more and more recognized as being involved in hepatic... 
Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Organic Anion Transporters, Sodium-Independent - genetics | Fatty Acids, Monounsaturated - pharmacology | Cricetulus | Hypolipidemic Agents - metabolism | Hypoglycemic Agents - metabolism | Taurocholic Acid - metabolism | Humans | Hepatocytes - metabolism | Simvastatin - pharmacology | Organic Anion Transporters - metabolism | Chromans - metabolism | Hepatocytes - cytology | Indoles - metabolism | Organic Anion Transporters - genetics | Drug Interactions | Anticholesteremic Agents - metabolism | Chromans - pharmacology | Fatty Acids, Monounsaturated - metabolism | Organic Anion Transporters, Sodium-Independent - metabolism | Indoles - pharmacology | Biological Transport - drug effects | Thiazolidinediones - pharmacology | Hepatocytes - drug effects | Solute Carrier Organic Anion Transporter Family Member 1B3 | CHO Cells | Pravastatin - pharmacology | Recombinant Proteins - metabolism | Taurocholic Acid - pharmacology | Cell Line | Cricetinae | Pravastatin - metabolism | Simvastatin - metabolism | Gemfibrozil - pharmacokinetics | Gemfibrozil - pharmacology | Hypolipidemic Agents - pharmacology | Thiazolidinediones - metabolism | Hypoglycemic Agents - pharmacology | Animals | Estrone - analogs & derivatives | Estrone - metabolism | Protein Binding | Fatty Acids, Monounsaturated - pharmacokinetics | Indoles - pharmacokinetics | Kinetics | Solute Carrier Organic Anion Transporter Family Member 1b1 | Anticholesteremic Agents - pharmacology | Gemfibrozil - metabolism | Index Medicus
Journal Article
European journal of clinical pharmacology, ISSN 0031-6970, 5/2012, Volume 68, Issue 5, pp. 709 - 714
Journal Article
Water research (Oxford), ISSN 0043-1354, 06/2018, Volume 137, pp. 242 - 250
Journal Article
Journal of neurochemistry, ISSN 0022-3042, 05/2017, Volume 141, Issue 3, pp. 423 - 435
Journal Article